Running on Empty: Navigating the GLP-1 and GIP/GLP-1 Receptor Agonist Drug Shortage Kimmy Nguyen May 27, 2024 4 min read Updated: Oct 30, 2025 By Sydnie Twillmann, PharmD Glucagon-like peptide 1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have been making the headlines recently, for more reasons than one
Do You Understand Restrictive Marketing Clauses
Irregular use, skipped doses, or inconsistent timing can affect how the body responds
A cool thing about Amino Asylum is that they have quite a few affiliate athletes
In healthy obese women, moderate improvements were seen when L-carnitine supplementation was combined with moderate aerobic training and a calorie-controlled diet
Important warnings and side effects include: GLP-1 agonist and GLP-1 / GIP agonist drugs like Saxenda (liraglutide), Foundayo (orforglipron) (Wegovy (semaglutide) and Zepbound (tirzepatide) all contain a Boxed Warning for thyroid C-cell tumor cancer